Table of Content




Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Application
1.1.3. End Use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1: Understanding the market dynamics
1.9.2. Objective 2: Understanding the market estimates and forecasts
1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
1.9.4. Objective 4: Understanding the key service scopes to conclude on the market size
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. ANZ Dental Biomaterials Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis, by Service
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.1.1. Growing prevalence of dental caries
3.4.1.2. Increasing awareness about oral health
3.4.1.3. Technological advancements pertaining to dental procedures
3.4.2. Market Restraint Analysis
3.4.2.1. Decrease government funding on dental care
3.4.3. Industry Challenges
3.4.3.1. Managing the relationships
3.5. ANZ Dental Biomaterials: Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier Power
3.5.1.2. Buyer Power
3.5.1.3. Substitution Threat
3.5.1.4. Threat from new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political Landscape
3.5.2.2. Environmental Landscape
3.5.2.3. Social Landscape
3.5.2.4. Type Landscape
3.5.2.5. Legal Landscape
3.5.3. Major Deals & Strategic Alliances Analysis
Chapter 4. ANZ Dental Biomaterials: Segment Analysis, by Type, 2016 - 2027 (USD Million)
4.1. Definitions & Scope
4.2. Type market share analysis, 2019 & 2027
4.3. Segment Dashboard
4.4. ANZ Dental Biomaterials Market, by Type, 2016 to 2027
4.5. Market Size & Forecasts and Trend Analysis, 2016 to 2027 for the following
4.5.1. Metallic Biomaterials
4.5.2. Ceramic Biomaterials
4.5.3. Polymeric Biomaterials
4.5.4. Metal-ceramic Biomaterials
4.5.5. Natural Biomaterials
4.5.6. Composites Biomaterials
Chapter 5. ANZ Dental Biomaterials: Segment Analysis, by Application, 2016 - 2027 (USD Million)
5.1. Definitions & Scope
5.2. Application market share analysis, 2019 & 2027
5.3. Segment Dashboard
5.4. ANZ Dental Biomaterials Market, by Application, 2016 to 2027
5.5. Market Size & Forecasts and Trend Analysis, 2016 to 2027 for the following
5.5.1. Orthodontics
5.5.2. Implantology
5.5.3. Prosthodontics
5.5.4. Others
Chapter 6. ANZ Dental Biomaterials: Segment Analysis, by End-Use, 2016 - 2027 (USD Million)
6.1. Definitions & Scope
6.2. End-use market share analysis, 2019 & 2027
6.3. Segment Dashboard
6.4. ANZ Dental Biomaterials Market, by End-Use, 2016 to 2027
6.5. Market Size & Forecasts and Trend Analysis, 2016 to 2027 for the following
6.5.1. Dental Hospitals and Clinics
6.5.2. Dental Laboratories
6.5.3. Dental Academies and Research Institutes
Chapter 7. ANZ Dental Biomaterials: Regional Market Analysis, 2016 - 2027 (USD Million)
7.1. Definitions & Scope
7.2. Regional Market Share Analysis, 2019 & 2027
7.3. Regional Market Dashboard
7.4. Regional Market Snapshot
7.5. Regional Market Share, 2018
7.6. Market Size, & Forecasts, and Trend Analysis, 2016 to 2027:
7.7. Australia
7.7.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
7.7.2. Market estimates and forecast, by Type, 2016 - 2027 (USD Million)
7.7.3. Market estimates and forecast, By Application, 2016 - 2027 (USD Million)
7.7.4. Market estimates and forecast, By End Use, 2016 - 2027 (USD Million)
7.8. New Zealand
7.8.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
7.8.2. Market estimates and forecast, by Type, 2016 - 2027 (USD Million)
7.8.3. Market estimates and forecast, By Application, 2016 - 2027 (USD Million)
7.8.4. Market estimates and forecast, By End Use, 2016 - 2027 (USD Million)
Chapter 8. ANZ Dental Biomaterials - Competitive Analysis
8.1. Key companies profiled
8.1.1. Straumann Holding AG
8.1.1.1. Company Overview
8.1.1.2. Financial Performance
8.1.1.3. Product Benchmarking
8.1.1.4. Strategic Initiatives
8.1.2. Geistlich Pharma AG
8.1.2.1. Company Overview
8.1.2.2. Financial Performance
8.1.2.3. Product Benchmarking
8.1.2.4. Strategic Initiatives
8.1.3. Zimmer Biomet Holding, Inc.
8.1.3.1. Company Overview
8.1.3.2. Financial Performance
8.1.3.3. Product Benchmarking
8.1.3.4. Strategic Initiatives
8.1.4. Danaher Corporation
8.1.4.1. Company Overview
8.1.4.2. Financial Performance
8.1.4.3. Product Benchmarking
8.1.4.4. Strategic Initiatives
8.1.5. Dentsply Sirona, Inc.
8.1.5.1. Company Overview
8.1.5.2. Financial Performance
8.1.5.3. Product Benchmarking
8.1.5.4. Strategic Initiatives
8.1.6. 3M Company
8.1.6.1. Company Overview
8.1.6.2. Financial Performance
8.1.6.3. Product Benchmarking
8.1.6.4. Strategic Initiatives
8.1.7. Royal DSM
8.1.7.1. Company Overview
8.1.7.2. Financial Performance
8.1.7.3. Product Benchmarking
8.1.7.4. Strategic Initiatives
8.1.8. Carpenter Technology Corporation
8.1.8.1. Company Overview
8.1.8.2. Financial Performance
8.1.8.3. Product Benchmarking
8.1.8.4. Strategic Initiatives
8.1.9. Kuraray Co. Ltd.
8.1.9.1. Company Overview
8.1.9.2. Financial Performance
8.1.9.3. Product Benchmarking
8.1.9.4. Strategic Initiatives
8.1.10. Medtronic
8.1.10.1. Company Overview
8.1.10.2. Financial Performance
8.1.10.3. Product Benchmarking
8.1.10.4. Strategic Initiatives
8.1.11. Henry Schein
8.1.11.1. Company Overview
8.1.11.2. Financial Performance
8.1.11.3. Product Benchmarking
8.1.11.4. Strategic Initiatives
8.1.12. Ivoclar Vivadent AG
8.1.12.1. Company Overview
8.1.12.2. Financial Performance
8.1.12.3. Product Benchmarking
8.1.12.4. Strategic Initiatives



List of Tables




Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 ANZ Dental Biomaterials Market, By Region 2016 - 2027 (USD Million)
Table 4 ANZ Dental Biomaterials Market, By Type, 2016 - 2027 (USD Million)
Table 5 ANZ Dental Biomaterials Market, By Application, 2016 - 2027 (USD Million)
Table 6 ANZ Dental Biomaterials Market, By End Use, 2016 - 2027 (USD Million)
Table 7 Australia ANZ Dental Biomaterials, By Country, 2016 - 2027 (USD Million)
Table 8 Australia ANZ Dental Biomaterials, By Type, 2016 - 2027 (USD Million)
Table 9 Australia ANZ Dental Biomaterials, By Application, 2016 - 2027 (USD Million)
Table 10 Australia ANZ Dental Biomaterials, By End Use, 2016 - 2027 (USD Million)
Table 11 New Zealand ANZ Dental Biomaterials, By Country, 2016 - 2027 (USD Million)
Table 12 New Zealand ANZ Dental Biomaterials, By Type, 2016 - 2027 (USD Million)
Table 13 New Zealand ANZ Dental Biomaterials, By Application, 2016 - 2027 (USD Million)
Table 14 New Zealand ANZ Dental Biomaterials, By End Use, 2016 - 2027 (USD Million)